Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Change in Account Payables (2018 - 2024)

Avai Bio's Change in Account Payables history spans 6 years, with the latest figure at $198294.0 for Q1 2024.

  • For Q1 2024, Change in Account Payables rose 564.39% year-over-year to $198294.0; the TTM value through Mar 2024 reached $844903.0, up 1896.7%, while the annual FY2025 figure was -$196536.0, 123.26% down from the prior year.
  • Change in Account Payables for Q1 2024 was $198294.0 at Avai Bio, down from $335000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $342709.0 in Q2 2023 and bottomed at -$42700.0 in Q1 2023.
  • The 4-year median for Change in Account Payables is $44071.5 (2022), against an average of $101799.5.
  • The largest annual shift saw Change in Account Payables surged 15159.26% in 2020 before it crashed 894.25% in 2023.
  • A 4-year view of Change in Account Payables shows it stood at $12198.0 in 2020, then soared by 58.06% to $19280.0 in 2022, then skyrocketed by 1637.55% to $335000.0 in 2023, then crashed by 40.81% to $198294.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Change in Account Payables are $198294.0 (Q1 2024), $335000.0 (Q4 2023), and -$31100.0 (Q3 2023).